Back to all bills
S 3188119th CongressIn Committee
Biomanufacturing Excellence Act of 2025
Introduced: Nov 18, 2025
Sponsor: Sen. Coons, Christopher A. [D-DE] (D-Delaware)
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Biomanufacturing Excellence Act establishes a National Biopharmaceutical Center of Excellence at NIST to advance biopharmaceutical manufacturing technologies, improve manufacturing processes, support workforce training, and strengthen domestic biotechnology capabilities. The center will receive $120 million in funding and operate through public-private partnerships.
Key Points
- 1Establishes National Biopharmaceutical Manufacturing Center of Excellence at NIST
- 2Authorizes $120 million for fiscal year 2026 to support the center
- 3Focuses on advancing biopharmaceutical manufacturing technologies and processes
- 4Requires development of flexible biomanufacturing technologies and improved upstream/downstream processes
- 5Mandates workforce training programs in partnership with educational institutions
- 6Requires annual progress reports to Congress on center activities and findings
Impact Areas
Biotechnology and biopharmaceutical manufacturingDomestic supply chain resilienceWorkforce development and trainingNational Institute of Standards and Technology programsPublic-private partnershipsEconomic competitiveness
Generated by kwaipilot/kat-coder-pro:free on Dec 6, 2025